home / stock / eltp / eltp news

ELTP News and Press, Elite Pharmaceuticals Inc. From 11/08/22

Stock Information
Company Name: Elite Pharmaceuticals Inc.
Stock Symbol: ELTP
Market: OTC
Website: elitepharma.com
Menu
ELTP ELTP Quote ELTP Short ELTP News ELTP Articles ELTP Message Board
Get ELTP Alerts

News, Short Squeeze, Breakout and More Instantly...
ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022

Financials for Second Quarter Fiscal Year 2023 Ended September 30, 2022 will be released on November 14, 2022 NORTHVALE, NJ / ACCESSWIRE / November 8, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic ...
ELTP - Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study

Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study NORTHVALE, NJ / ACCESSWIRE / November 2, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today reported po...

ELTP - The 7 Best Penny Stocks for 10 Cents or Less

InvestorPlace - Stock Market News, Stock Advice & Trading Tips When talking about penny stocks for 10 cents or less, the term “best” may not be a word that first comes to mind. Many penny stocks, almost all of which trade over-the-counter (or OTC) rather than on a major e...

ELTP - Elite Pharmaceuticals, Inc. (ELTP) CEO Nasrat Hakim on Q1 2023 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q1 2023 Earnings Conference Call August 16, 2022 11:30 AM ET Company Participants Nasrat Hakim - President and Chief Executive Officer Robert Chen - Chief Financial Officer, Secretary and Treasurer Conference Call Participants...
ELTP - Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $7.7M

Elite Pharmaceuticals press release ( OTCQB:ELTP ): Q1 GAAP EPS of $0.00. Revenue of $7.7M (+2.7% Y/Y). For further details see: Elite Pharmaceuticals GAAP EPS of $0.00, revenue of $7.7M

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Information

Conference Call Scheduled for Tuesday, August 16 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / August 15, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company")(OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the first quart...

ELTP - Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022

Financials for First Quarter Fiscal Year 2023 Ended June 30, 2022 will be released on August 15, 2022 NORTHVALE, NJ / ACCESSWIRE / August 11, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products,...
ELTP - Elite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcript

Elite Pharmaceuticals, Inc. (ELTP) Q4 2022 Earnings Conference Call June 30, 2022, 11:30 AM ET Company Participants Nasrat Hakim - President and CEO Robert Chen - Chief Financial Officer Dianne Will - Vice President, Investor Relations Conference Call Parti...

ELTP - Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Information

Conference Call Scheduled for Thursday, June 30 at 11:30 AM EDT NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, announced results for the fiscal year e...

ELTP - Elite Pharmaceuticals Receives FDA Approval for Generic Sabril(R)

NORTHVALE, NJ / ACCESSWIRE / June 29, 2022 / Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (OTCQB:ELTP), a specialty pharmaceutical company developing niche generic products, today announced that it received approval from the US Food and Drug Administration (FDA) for an Abbreviated ...
Previous 10 Next 10